Amendment of Schedule 3 to the 1994 Regulations
regulation 3(9) of The Medicines for Human Use (Marketing Authorisations Etc.) Amendment Regulations 2008 (revoked)
- Status not determined
- Strict liability
- Drugs and medicines
This offence was read from the text as made, and no revised version was available, so a later revocation could not be ruled out. Check the current text at legislation.gov.uk.
What the provision says
3 Where the holder of
a United Kingdom marketing authorization (“H”) has instigated or conducted
a paediatric clinical trial in the United Kingdom which ended on or after 26th January 2007 but before 29th December 2008 in respect of the product to which the authorization relates and the trial is not included in
a paediatric investigation plan, H shall be guilty of an offence if H fails to submit the results of that trial to the EMEA on or before 29th June 2009, as required by Article 41(2) of the Paediatric Regulation.
Text as made, from legislation.gov.uk. © Crown copyright, reused under the Open Government Licence v3.0. This is the text as originally made; later amendments are not shown here.
Who it binds, and what has to be proved
- Binds
- a person
- Conduct
- failing to do something the instrument requires
- Fault element
- Strict liability
- Burden of proof
- No statutory defence — prosecution proves everything
The prosecution must prove that the conduct happened. This is a strict liability offence as drafted: the provision uses no word of intention, knowledge, recklessness or negligence, so there is no need to show that a person meant to do it, knew about it, or was careless.
Intention, knowledge and carelessness are irrelevant to guilt. They may still matter a great deal to sentence.
The provision states no defence, so the prosecution bears the burden on every element of the offence.
Classifier’s reasoning: no word of intention, knowledge, recklessness or negligence in the offence or its provision.
What would breach regulation 3(9)?
These are illustrations, not law. They are generated from the provision’s own words to show the shape of the offence. Whether any particular conduct is caught depends on the full text, on any amendment since, and on the facts.
- Not doing what the provision requires under the Medicines for Human Use (Marketing Authorisations Etc.) Amendment Regulations 2008, by the time it requires it to be done.
- Doing it, but not in the manner or to the standard the instrument specifies.
Penalty
- Mode of trial
- Not determined
- Maximum fine
- Not determined
- Maximum prison (summary)
- Not determined
no penalty is stated here: this instrument amends another one, and the penalty for the offence is in the instrument being amended.
No penalty was determined from this instrument. It may be in the enabling Act, or in a general penalties provision this pass did not connect to the offence. Absence of a figure here is not evidence that the offence carries no penalty.
Sentencing
Offences of this kind are usually sentenced under the guidelines below. This is a mapping by subject, not a finding about this provision, and the links go to a search of the Sentencing Council’s own site.
-
Drug offences: definitive guideline
Magistrates' courts and the Crown Court in England and Wales
Covers importation, supply, production and possession of controlled drugs, with sentencing driven by drug class and the offender's role.
-
Reduction in sentence for a guilty plea: definitive guideline
All courts in England and Wales · in force from 1 June 2017
The sliding scale of credit for pleading guilty, from one third at the first stage of proceedings downwards.
-
General guideline: overarching principles
All courts in England and Wales · in force from 1 October 2019
The guideline a court uses when there is no offence-specific guideline, which is the position for the overwhelming majority of offences created by statutory instrument. It sets out how culpability and harm are assessed from first principles.
-
Totality: definitive guideline
All courts in England and Wales
How to sentence more than one offence at once so that the total is just and proportionate - frequently in point here, because regulatory prosecutions commonly charge several breaches of the same instrument.
Prosecution figures
No published per-offence figure was found for this provision, and it could not be matched to a Ministry of Justice offence code. Offences created by statutory instrument very largely do not have one. Absence of a figure is not evidence that the offence is unused.
Status and lifecycle
- Current status
- Status not determined
- Made
- 3 December 2008
- In force from
- 29 December 2008
- Extent
- Not stated
How this was established: read from the text as made; no revised version available, so later revocation could not be ruled out.
What the instrument is for
(This note is not part of the Regulations) — the explanatory note published with the instrument, © Crown copyright.
These Regulations provide for the enforcement in the United Kingdom of Regulation (EC) No 1901/2006 of the European Parliament and of the Council on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004, as amended by Regulation (EC) No 1902/2006 of the European Parliament and of the Council amending Regulation 1901/2006 on medicinal products for paediatric use (the Paediatric Regulation). The Paediatric Regulation establishes a scheme of obligations and incentives to encourage the development of, and improve access to, medicines for children. The Paediatric Regulation is enforced through amendments to the Medicines for Human Use (Marketing Authorisation Etc.) Regulations (“the 1994 Regulations”). The 1994 Regulations are the primary piece of legislation through which Community obligations in relation to medicines are implemented. These Regulations also further amend the 1994 Regulations in connection with transposition of Directive 2001/83 of the European Parliament and Council on the Community Code relating to medicinal products for human use. Regulation 2 amends regulation 1 of the 1994 Regulations to update references to Community legislation amended by the Paediatric Regulation; and to identify the Paediatric Regulation as a “relevant Community Provision” for the purpose of the 1994 Regulations. Regulation 3 amends Schedule 3 to the 1994 Regulations by inserting various additional criminal offences through which provisions of the Paediatric Regulation can be enforced and by clarifying certain aspects of the information-reporting obligations in that Schedule. Regulation 4 updates references to Community legislation in the Medicines Act 1968 to include the Paediatric Regulation. Regulation 5 corrects a typographical error in the Medicines for Human Use (Prescribing by EEA Practitioners) Regulations 2008. A full impact assessment has not been produced for this instrument as no impact on the private and voluntary sectors is foreseen.
Read the full note and every offence in this instrument
Other offences in the same instrument
- the following paragraphs— 6BA Where the holder of a United Kingdom marketing authorization (“H”) has…regulation 3(4)
- the following paragraph— 6G Any person who— a is the holder of a United Kingdom marketing authorization; b…regulation 3(5)
- the following paragraph— 13B 1 Any person established in the United Kingdom to whom a decision by the EMEA…regulation 3(9)
- Where the holder of a United Kingdom marketing authorization (“H”) instigates or conducts a paediatric…regulation 3(9)
- Any person who— a is the sponsor of a paediatric clinical trial in the United Kingdom in respect of a…regulation 3(9)
- Any person who— a has sponsored a paediatric clinical trial in the United Kingdom in respect of a medicinal…regulation 3(9)
- Any holder of a United Kingdom marketing authorization who— a has knowledge of a paediatric study in respect…regulation 3(9)
- Any holder of a United Kingdom marketing authorization who— a sponsors a paediatric study in respect of the…regulation 3(9)
- Any holder of a United Kingdom marketing authorization who— a has sponsored a paediatric study in respect of…regulation 3(9)
How this was identified as an offence
Everything above rests on the judgement that this provision creates a criminal offence, rather than mentioning one. That judgement is made by rule, from the words of the provision, and this is the rule that made it — with a confidence of 0.92.
- Basis
- the provision says a person is “guilty of an offence”
- Confidence
- 0.92 of 1.00
A provision that states a penalty for an offence created elsewhere can read very like one that creates an offence, and the rules can mistake the one for the other. If the text quoted above sets a penalty for something made an offence by another provision, treat the classification on this page with that in mind, and read the instrument.
Check the source
- This provision on legislation.gov.uk The authoritative text. Check it before relying on anything here.
- The Medicines for Human Use (Marketing Authorisations Etc.) Amendment Regulations 2008 (revoked) Every offence this instrument creates, and its explanatory note
- Drugs and medicinesOther offences on the same subject
- Offences created in 2008